The importance of PR signaling in mutant Brca1 tumorigenesis was further demonstrated by Poole et al. 3 who showed that tumor development in Brca1/p53 deficient mice could be prevented by the PR antagonist RU-486. This evidence concerns the gene PGR and neoplasm.